ISRCTN52817670已完成3 期
A randomised two-arm, prospective, multi-centre, open-label phase III trial comparing the activity and safety of a weekly versus a three-weekly paclitaxel treatment schedule in patients with advanced or metastatic breast cancer
Anglo Celtic Cooperative Oncology Group (UK)0 个研究点目标入组 600 人开始时间: 2002年10月15日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically proven breast cancer
- •2. Locally advanced or metastatic disease
- •3. Presence of measurable or evaluable lesions
- •4. Prior treatment with anthracyclines (either in the adjuvant setting or for metastatic disease) or contraindication to anthracyclines
- •5. Aged 18 years or greater
- •6. World Health Organization (WHO)/Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2
- •7. Adequate haematological, renal and hepatic function
- •8. Written informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
不适用
A prospective, multi-centre, randomised, double-blind, placebo-controlled comparison of intravenous dexmedetomidine with haloperidol in treatment of hyperactive delirium after heart surgery. - Dex-in-delirPostoperative hyperactive deliriumMedDRA version: 12.0Level: LLTClassification code 10000702Term: Acute deliriumMedDRA version: 12.0Level: LLTClassification code 10049989Term: Agitation postoperativeMedDRA version: 12.0Level: LLTClassification code 10056436Term: Psychomotor agitationMedDRA version: 12.0Level: LLTClassification code 10049987Term: Confusion postoperativeEUCTR2008-007384-17-SESten Walther75
进行中（未招募）
1 期
Randomized, multicentre, prospective, two-arm, open-label Phase II study to investigate the efficacy and safety of two ZK219477 i.v. infusions (3-hour infusion of 16mg/m2 versus 0.5-hour infusion of 16mg/m2) in patients with recurrent ovarian cancer progressing during, or within 6 months of the end of platinum-based chemotherapyEUCTR2005-000635-15-GBSchering AG
进行中（未招募）
3 期
A comparative clinical trial to understand efficacy and safety of R-TPR-012/ Metalyse® in Patients with heart attackCTRI/2016/09/007230Reliance Life sciences Pvt Ltd
已完成
3 期
Efficacy of strontium ranelate versus placebo on the time to fracture healing in osteoporotic men and osteoporotic post-menopausal womeRadius fracture, OsteoporosisMusculoskeletal DiseasesOsteoporosis with pathological fractureISRCTN51868986Institut de Recherches Internationales Servier (France)217
进行中（未招募）
不适用
A multi-centre, open-label, randomised, two-arm Phase III trial of bevacizumab plus chemotherapy versus chemotherapy alone in patients with platinum-resistant, epithelial ovarian, fallopian tube or primary peritoneal cancer. - AureliaPlatinum-resistant, epithelial ovarian, fallopian tube or primary peritoneal cancer.MedDRA version: 9.1Level: LLTClassification code 10033128MedDRA version: 9.1Level: LLTClassification code 10016180MedDRA version: 9.1Level: LLTClassification code 10061344EUCTR2009-011400-33-ITF. Hoffmann - La Roche Ltd300